Intratympanic steroid via saturated gelfoam vs. intratympanic injection for sudden sensorineural hearing loss
- 8 May 2025
- journal article
- Published by Elsevier in Auris Nasus Larynx
- Vol. 52 (4) , 314-318
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Evaluation and comparison of the efficacy of long-acting betamethasone and dexamethasone as injections in the treatment of idiopathic sudden hearing lossAmerican Journal of Otolaryngology, 2021
- Residual Perforation Risk Assessment of Intratympanic Steroids via Tympanostomy Tube Versus Transtympanic InjectionsThe Laryngoscope, 2021
- Comparison of two different intratympanic corticosteroid injection protocols as salvage treatments for idiopathic sudden sensorineural hearing lossEuropean Archives of Oto-Rhino-Laryngology, 2021
- Dexamethasone eardrop with grommet placement vs intratympanic steroid injection for sudden sensorineural hearing loss: A randomized prospective clinical trialAmerican Journal of Otolaryngology, 2020
- Potential benefits of salvage intratympanic dexamethasone injection in profound idiopathic sudden sensorineural hearing lossEuropean Archives of Oto-Rhino-Laryngology, 2020
- Intratympanic dexamethasone in sudden sensorineural hearing loss: A systematic review and meta‐analysisThe Laryngoscope, 2016
- Intratympanic steroid therapy in moderate sudden hearing loss: A randomized, triple‐blind, placebo‐controlled trialThe Laryngoscope, 2013
- Sudden Sensorineural Hearing Loss: An Otologic EmergencyIndian Journal of Otolaryngology and Head & Neck Surgery, 2011
- The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing lossEuropean Archives of Oto-Rhino-Laryngology, 2011
- The Efficacy of Steroids in the Treatment of Idiopathic Sudden Hearing Loss: A Double-blind Clinical StudyJAMA Otolaryngology–Head & Neck Surgery, 1980